close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Business Exposures
< Previous 1 2
...
7 8 9 10 11 12 13 14 15
...
99 100 Next >
Class Action Filed Against Unicycive Therapeutics, Inc. (UNCY) - October 14, 2025 Deadline to Join - Contact Levi &amp; Korsinsky
Via TheNewswire.com
Topics Fraud Lawsuit
Tickers UNCY
Exposures Financial Legal Product Safety
OS Therapies Provides OST-HER2 UK MHRA and US FDA Osteosarcoma Regulatory Update
Via Newsfile
Tickers OSTX
Exposures Product Safety
Aurinia Pharma Stands By Lupus Drug After FDA Official’s Retracted Post Sparks 16% Selloff — Retail Stays Bullish On Recovery
Via Stocktwits
Tickers AUPH
Exposures Product Safety
Dollar Dips as Government Shutdown Looms: A Volatile Start to Q4 2025
Via MarketMinute
Topics Bonds Economy Government
Tickers AAPL BAH DAL JNJ JPM LMT
Exposures Debt Markets Economy Interest Rates
IO Biotech Stock Plunges After FDA Recommends Another Trial For Investigational Cancer Vaccine
Via Stocktwits
Tickers IOBT MRK
Exposures Product Safety
Global Markets Brace for Impact as US Government Shutdown Looms
Via MarketMinute
Topics Bonds Economy Workforce
Tickers ABX BAC GOLD JPM LMT MRNA
Exposures Debt Markets Economy Interest Rates
Merus N.V. Soars on $8 Billion Genmab Acquisition, Propelled by Oncology Pipeline Successes
Via MarketMinute
Tickers BMY GILD GMAB INCY LLY MRK
Exposures Product Safety
NeuroOne(R) Announces Virtual Investor Webinar on October 7, 2025 at 8:30 a.m. EST
Via TheNewswire.com
Topics Artificial Intelligence
Tickers NMTC
Exposures Artificial Intelligence Product Safety
NeuroOne(R) Announces Virtual Investor Webinar on October 7, 2025 at 8:30 a.m. EST
Via NewMediaWire
Topics Artificial Intelligence
Tickers NMTC
Exposures Artificial Intelligence Product Safety
$750 Million Market Projected to Reach $3.35 Billion; Huge Opportunity for Superior Preservative-Free Ketamine Drug Treating Suicidal Depression $NRXP
Via PRLog
Exposures Product Safety
$750 Million Market Projected to Reach $3.35 Billion in 2034; Mega Opportunity for Superior Preservative-Free Ketamine Drug Treating Suicidal Depression: NRx Pharmaceuticals, Inc. (Nasdaq: NRXP)
Via Get News
Tickers NRXP
Exposures Product Safety
New Teletherapy Program From Moment of Clarity Enhances Access to Mental Health Treatment
Via Press Advantage
Exposures Product Safety
AI Reshapes Healthcare: A Deep Dive into Innovation, Regulation, and Market Impact
Via MarketMinute
Topics Artificial Intelligence Fraud
Tickers CTSH MDRX ORCL UNH
Exposures Artificial Intelligence Legal Product Safety
Ian Chait Brings Four Decades of Experience to Real Estate Leadership in Arizona
Via Get News
Topics Product Recall
Exposures Legal Product Safety
The Digital Pulse: Nursing Informatics and CNIOs Steer Healthcare's Digital Revolution
Via MarketMinute
Topics Artificial Intelligence
Tickers AMWL ORCL TDOC
Exposures Artificial Intelligence COVID-19 Product Safety
Why Guardant Health (GH) Stock Is Trading Up Today
Via StockStory
Tickers GH JPM LLY WFC
Exposures Product Safety
InvestorNewsBreaks – NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Re-files ANDA for Preservative-Free IV Ketamine KETAFREE(TM)
Via Investor Brand Network
Tickers NRXP
Exposures Product Safety
Dow Futures Defy Shutdown Fears: A Deep Dive into Market Resilience
Via MarketMinute
Topics Artificial Intelligence Economy Stocks
Tickers ABX BA BAH BIIB DAL GOLD
Exposures Artificial Intelligence Economy Interest Rates
Nasus Pharma Receives $22 Price Target and Buy Rating From Laidlaw & Company
Via AB Newswire
Tickers NSRX
Exposures COVID-19 Product Safety
Palantir Technologies: Decoding the Data Giant’s AI Ambitions and Geopolitical Influence
Via PredictStreet
Topics Artificial Intelligence Earnings Fraud
Tickers BA JPM PLTR PYPL RACE
Exposures Artificial Intelligence Financial Legal
U.S. Government Teeters on Brink of Shutdown: Markets Brace for Uncertainty Amidst Data Blackout Fears
Via MarketMinute
Topics Bonds Economy Government
Tickers AAL ABX AEP BAC D DAL
Exposures Debt Markets Economy Immigration
GSK Leaps Into Buy Zone On Surprise Departure Of CEO Emma Walmsley
Via Investor's Business Daily
Tickers AZN GSK RHHBY SNY
Exposures Product Safety
Contact Levi & Korsinsky by October 14, 2025 Deadline to Join Class Action Against Unicycive Therapeutics, Inc. (UNCY)
Via NewMediaWire
Topics Fraud Lawsuit
Tickers UNCY
Exposures Financial Legal Product Safety
Contact Levi &amp; Korsinsky by October 14, 2025 Deadline to Join Class Action Against Unicycive Therapeutics, Inc. (UNCY)
Via TheNewswire.com
Topics Fraud Lawsuit
Tickers UNCY
Exposures Financial Legal Product Safety
Lost Money on Cytokinetics, Incorporated (CYTK)? Join Class Action Suit Seeking Recovery - Contact Levi &amp; Korsinsky
Via TheNewswire.com
Topics Earnings Fraud Lawsuit
Tickers CYTK
Exposures Financial Legal Product Safety
Lost Money on Cytokinetics, Incorporated (CYTK)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky
Via NewMediaWire
Topics Earnings Fraud Lawsuit
Tickers CYTK
Exposures Financial Legal Product Safety
Savara Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - SVRA
Via NewMediaWire
Topics Fraud Lawsuit
Tickers SVRA
Exposures Financial Legal Product Safety
Savara Inc. Sued for Securities Law Violations - Investors Should Contact Levi &amp; Korsinsky for More Information - SVRA
Via TheNewswire.com
Topics Fraud Lawsuit
Tickers SVRA
Exposures Financial Legal Product Safety
Glacier Fresh Introduces the 3G Countertop Water Filter System for Enhanced Home Hydration
Via 24-7 Press Release
Exposures Product Safety Regulatory
Global Stock Futures Brace for Impact as US Government Shutdown Looms
Via MarketMinute
Topics Bonds Economy Government
Tickers AAL AEP DAL HLT MAR UAL
Exposures Debt Markets Economy Interest Rates
< Previous 1 2
...
7 8 9 10 11 12 13 14 15
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at $3.75/week.

Subscribe Today